MedTrace Logo

Haematological Indices in Systemic Lupus Erythematosus

NCT04110184 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2019-10-01

No results posted yet for this study

Summary

The aim of this study is to investigate the value of several hematological indices such as:

* neutrophil-lymphocyte ratio.
* platelet-lymphocyte ratio.
* red blood cell distribution width.
* mean platelet volume (MPV), RDW/platelet ratio.
* neutrophil / C3 ratio.
* All these as biomarkers of activity in systemic lupus erythematosis patients.

Conditions

Interventions

OTHER

Systemic lupus erythematosus disease activity index (SLEDAI)

The SLEDAI score ranges between 0 and 105, and scores ≥8 represent active disease

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2022-12-01
Completion
2023-02-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04110184 on ClinicalTrials.gov